Carmen Bozic insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Carmen reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | VRTX | ↓ Sell | 1,020 | $462.17 | $471K | Direct | Jun 23, 2026 (5d) |
| Jun 15, 2026 | VRTX | ↓ Sell | 4,062 | $450.00 | $1.8M | Direct | Jun 17, 2026 (2d) |
| Jun 5, 2026 | VRTX | ↓ Sell | 1,745 | $450.00 | $785K | Direct | Jun 9, 2026 (4d) |
| May 29, 2026 | VRTX | ↓ Sell | 1,974 | $450.00 | $888K | Direct | Jun 2, 2026 (4d) |
| May 15, 2026 | VRTX | ↓ Sell | 1,354 | $453.45 | $614K | Direct | May 19, 2026 (4d) |
| May 12, 2026 | VRTX | ↓ Sell | 6,988 | $450.00 | $3.1M | Direct | May 14, 2026 (2d) |
| Mar 27, 2026 | VRTX | ↓ Sell | 2,329 | $450.95 | $1.1M | Direct | Mar 31, 2026 (4d) |
| Mar 13, 2026 | VRTX | ↓ Sell | 2,329 | $481.79 | $1.1M | Direct | Mar 17, 2026 (4d) |
| Feb 27, 2026 | VRTX | ↓ Sell | 2,329 | $480.31 | $1.1M | Direct | Mar 3, 2026 (4d) |
| Aug 7, 2024 | VRTX | ↓ Sell | 2,280 | $476.75 | $1.1M | Direct | Aug 8, 2024 (1d) |
| Jul 24, 2024 | VRTX | ↓ Sell | 2,280 | $488.46 | $1.1M | Direct | Jul 25, 2024 (1d) |
| Jul 10, 2024 | VRTX | ↓ Sell | 2,280 | $487.34 | $1.1M | Direct | Jul 12, 2024 (2d) |
| Jun 26, 2024 | VRTX | ↓ Sell | 2,280 | $471.72 | $1.1M | Direct | Jun 28, 2024 (2d) |
| Jun 12, 2024 | VRTX | ↓ Sell | 2,280 | $478.00 | $1.1M | Direct | Jun 13, 2024 (1d) |
| May 29, 2024 | VRTX | ↓ Sell | 2,280 | $445.56 | $1.0M | Direct | May 31, 2024 (2d) |
| Nov 14, 2023 | VRTX | ↓ Sell | 5,650 | $380.82 | $2.2M | Direct | Nov 16, 2023 (2d) |
| Oct 31, 2023 | VRTX | ↓ Sell | 5,651 | $355.92 | $2.0M | Direct | Nov 2, 2023 (2d) |
| Oct 17, 2023 | VRTX | ↓ Sell | 5,651 | $373.25 | $2.1M | Direct | Oct 19, 2023 (2d) |
| Oct 3, 2023 | VRTX | ↓ Sell | 5,651 | $345.28 | $2.0M | Direct | Oct 5, 2023 (2d) |
| Sep 19, 2023 | VRTX | ↓ Sell | 5,651 | $351.00 | $2.0M | Direct | Sep 21, 2023 (2d) |
| Sep 5, 2023 | VRTX | ↓ Sell | 5,651 | $352.66 | $2.0M | Direct | Sep 7, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Carmen Bozic's insider trades
Carmen Bozic is EVP and CMO at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Sep 5, 2023, Carmen has reported no open-market purchases and 21 sales worth $29.7M on SEC Form 4. In the last 12 months: 9 sales ($11.0M).
Their filings also include shares withheld for taxes (23 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.